Get started
Author

Hidetoshi Furuie

Observed names: Furuie, Hidetoshi, H FURUIE, H Furuie, H. Furuie, Hidetoshi FURUIE
Observed institutions: Kyushu University, Oita University, Novartis (Japan), SOUSEIKAI Global Clinical Research Center, Osaka Hospital, Bayer (Japan)
ORCID: 0000-0002-8256-0516
Observed ORCID: 0000-0002-8256-0516
OpenAlex ID: A5055533000
Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as anin vivoinhibitor of BCRP
2012 · Hiroyuki Kusuhara, Hidetoshi Furuie, et al. · British Journal of Pharmacology · 153
PDF
Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects
2000 · H TAKANAGA, A OHNISHI, et al. · Clinical Pharmacology & Therapeutics · 130
Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes
2001 · Y. Horai, M. Kimura, et al. · Alimentary Pharmacology & Therapeutics · 117
Intrapulmonary pharmacokinetics of cefiderocol, a novel siderophore cephalosporin, in healthy adult subjects
2019 · Takayuki Katsube, Yutaka Saisho, et al. · Journal of Antimicrobial Chemotherapy · 77
PDF
Single‐ and multiple‐dose escalation study to assess pharmacokinetics, pharmacodynamics and safety of oral esaxerenone in healthy Japanese subjects
2018 · Manabu Kato, Hidetoshi Furuie, et al. · British Journal of Clinical Pharmacology · 52
PDF
Pharmacokinetics and Pharmacodynamics of Landiolol Hydrochloride, an Ultra Short-acting β1-Selective Blocker, in a Dose Escalation Regimen in Healthy Male Volunteers
2005 · Makoto Murakami, Hidetoshi Furuie, et al. · Drug Metabolism and Pharmacokinetics · 47
Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial
2018 · Yuji Kumagai, Hideki Amano, et al. · British Journal of Clinical Pharmacology · 37
PDF
Intrapulmonary Distribution and Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Inhaled Administration of Its Prodrug, Laninamivir Octanoate, in Healthy Volunteers
2012 · Hitoshi Ishizuka, Kaoru Toyama, et al. · Antimicrobial Agents and Chemotherapy · 35
Oral Semaglutide in an East Asian Population With Overweight or Obesity, With or Without Type 2 Diabetes
2025 · Takashi Kadowaki, Line Dam Heftdal, et al. · JAMA Internal Medicine · 30
AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects
2019 · Hiroyuki Fukase, Toshifumi Kajioka, et al. · British Journal of Clinical Pharmacology · 23
PDF
Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers
2018 · Hidetoshi Furuie, Sayoko Tanioka, et al. · Antimicrobial Agents and Chemotherapy · 22
Assessment of the immunogenicity and safety of varying doses of an MF59®-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects
2012 · Hiroyuki Fukase, Hidetoshi Furuie, et al. · Vaccine · 21
Intrapulmonary Pharmacokinetics of S-013420, a Novel Bicyclolide Antibacterial, in Healthy Japanese Subjects
2009 · Hidetoshi Furuie, Yutaka Saisho, et al. · Antimicrobial Agents and Chemotherapy · 21
Absolute Bioavailability of Esaxerenone and Food Effects on its Pharmacokinetics After a Single Oral Dose in Healthy Japanese Subjects: An Open-Label Crossover Study
2019 · Akifumi Kurata, Hidetoshi Furuie, et al. · Advances in Therapy · 19
PDF
Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
2023 · Hidenobu Tanihara, Tetsuya Yamamoto, et al. · Advances in Therapy · 18
PDF
Safety and Pharmacokinetics of DS-8500a, a Novel GPR119 Agonist, After Multiple Oral Doses in Healthy Japanese Males
2018 · Manabu Kato, Hidetoshi Furuie, et al. · Clinical Drug Investigation · 12
Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)
2023 · Hironori Nakagami, Tetsuya Matsumoto, et al. · Vaccines · 9
PDF
Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers
2019 · Hidetoshi Furuie, Hironori Kanda · Clinical Drug Investigation · 9
PDF
Intrapulmonary Pharmacokinetics of Laninamivir, a Neuraminidase Inhibitor, after a Single Nebulized Administration of Laninamivir Octanoate in Healthy Japanese Subjects
2017 · Kaoru Toyama, Hidetoshi Furuie, et al. · Antimicrobial Agents and Chemotherapy · 7
Effects of Fexofenadine Hydrochloride on Psychomotor Performance: Comparison of Impaired Performance of a Word Processor by Fexofenadine Hydrochloride with that by d-Chlorpheniramine Maleate in Healthy Volunteers.
2000 · Akinori URAE, Mitsuko OKADA, et al. · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 7
PDF
Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study
2020 · Hiroyuki Fukase, Toshifumi Kajioka, et al. · Clinical Drug Investigation · 5
PDF
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects
2019 · Yutaro Maekawa, Hidetoshi Furuie, et al. · Clinical Drug Investigation · 5
Effects of Repeated Oral Administration of Esaxerenone on the Pharmacokinetics of Midazolam in Healthy Japanese Males
2021 · Kaoru Toyama, Hidetoshi Furuie, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 3
PDF
Safety and Pharmacokinetics of Nebulized Laninamivir Octanoate, A Long Acting Neuraminidase Inhibitor, In Healthy Subjects
2017 · K. Toyama, H. Furuie, et al. · Clinical Therapeutics · 3
PDF
Pharmacokinetic Bioequivalence Studies of an Extended-Release Oxycodone Hydrochloride Tablet in Healthy Japanese Subjects Under Fasting and Fed Conditions Without an Opioid Antagonist
2017 · Kaoru Toyama, Hidetoshi Furuie, et al. · Drugs in R&D · 3
PDF
Works count: 39
Citation count: 874
H-index: 15
I10-index: 16
Year
Topic
Type